Navidea Biopharmaceuticals Inc (NAVB)
0.042
+0.01
(+22.81%)
USD |
OTCM |
Apr 17, 15:27
Navidea Biopharmaceuticals Enterprise Value: 1.100M for April 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 16, 2024 | 1.100M |
| April 15, 2024 | 1.680M |
| April 12, 2024 | 1.680M |
| April 11, 2024 | 1.49M |
| April 10, 2024 | 1.48M |
| April 09, 2024 | 1.800M |
| April 08, 2024 | 2.481M |
| April 05, 2024 | 1.630M |
| April 04, 2024 | 2.681M |
| April 03, 2024 | 1.270M |
| April 02, 2024 | 1.405M |
| April 01, 2024 | 0.9796M |
| March 28, 2024 | 1.330M |
| March 27, 2024 | 1.230M |
| March 26, 2024 | 1.290M |
| March 25, 2024 | 1.980M |
| March 22, 2024 | 1.780M |
| March 21, 2024 | 1.980M |
| March 20, 2024 | 2.671M |
| March 19, 2024 | 1.680M |
| March 18, 2024 | 1.390M |
| March 15, 2024 | 1.390M |
| March 14, 2024 | 2.161M |
| March 13, 2024 | 1.580M |
| March 12, 2024 | 1.380M |
| Date | Value |
|---|---|
| March 11, 2024 | 0.9796M |
| March 08, 2024 | 1.380M |
| March 07, 2024 | 1.670M |
| March 06, 2024 | 1.610M |
| March 05, 2024 | 1.080M |
| March 04, 2024 | 1.280M |
| March 01, 2024 | 1.48M |
| February 29, 2024 | 1.930M |
| February 28, 2024 | 1.905M |
| February 27, 2024 | 1.680M |
| February 26, 2024 | 1.680M |
| February 23, 2024 | 2.181M |
| February 22, 2024 | 2.196M |
| February 21, 2024 | 2.471M |
| February 20, 2024 | 2.681M |
| February 16, 2024 | 1.830M |
| February 15, 2024 | 2.348M |
| February 14, 2024 | 2.451M |
| February 13, 2024 | 1.400M |
| February 12, 2024 | 1.130M |
| February 09, 2024 | 1.180M |
| February 08, 2024 | 1.404M |
| February 07, 2024 | 1.53M |
| February 06, 2024 | 1.580M |
| February 05, 2024 | 1.780M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.8294M
Minimum
Oct 10 2023
125.48M
Maximum
Aug 03 2020
26.89M
Average
18.80M
Median
Dec 27 2019
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 849.38M |
| Electromed Inc | 113.48M |
| Xtant Medical Holdings Inc | 118.85M |
| Asensus Surgical Inc | 49.92M |
| Senseonics Holdings Inc | 161.04M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.255M |
| Total Expenses (Quarterly) | 2.131M |
| EPS Diluted (Quarterly) | -0.02 |
| Earnings Yield | -142.9% |
| Normalized Earnings Yield | -1333.33 |